Progyny Inc
NASDAQ:PGNY
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
13.9
41.62
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one PGNY stock under the Base Case scenario is 40.42 USD. Compared to the current market price of 13.9 USD, Progyny Inc is Undervalued by 66%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Progyny Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for PGNY cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Progyny Inc
Balance Sheet Decomposition
Progyny Inc
Current Assets | 582.2m |
Cash & Short-Term Investments | 262.2m |
Receivables | 293.8m |
Other Current Assets | 26.3m |
Non-Current Assets | 116.4m |
PP&E | 28.4m |
Intangibles | 17.1m |
Other Non-Current Assets | 70.9m |
Current Liabilities | 225.4m |
Accounts Payable | 151.7m |
Accrued Liabilities | 73.6m |
Non-Current Liabilities | 17.1m |
Other Non-Current Liabilities | 17.1m |
Earnings Waterfall
Progyny Inc
Revenue
|
1.1B
USD
|
Cost of Revenue
|
-882.8m
USD
|
Gross Profit
|
250.2m
USD
|
Operating Expenses
|
-179m
USD
|
Operating Income
|
71.2m
USD
|
Other Expenses
|
-8.5m
USD
|
Net Income
|
62.8m
USD
|
Free Cash Flow Analysis
Progyny Inc
USD | |
Free Cash Flow | USD |
PGNY Profitability Score
Profitability Due Diligence
Progyny Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Score
Progyny Inc's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
PGNY Solvency Score
Solvency Due Diligence
Progyny Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Progyny Inc's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PGNY Price Targets Summary
Progyny Inc
According to Wall Street analysts, the average 1-year price target for PGNY is 24.19 USD with a low forecast of 18.18 USD and a high forecast of 31.5 USD.
Dividends
Current shareholder yield for PGNY is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Progyny, Inc. is a fertility benefits management company. The company is headquartered in New York City, New York and currently employs 311 full-time employees. The company went IPO on 2019-10-25. The firm specializes in fertility and family building benefits solutions in the United States. The firm provides its benefit through its Smart Cycle approach. The Smart Cycle includes medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition, to its fertility benefits solution, it offers an integrated pharmacy benefits solution, Progyny Rx, which is added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. As part of this solution, the Company provide care management services, which include its formulary plan design, simplified authorization, assistance with prescription fulfillment and timely delivery of the medications by its network of specialty pharmacies, as well as medication administration training, pharmacy support services and patient care advocates.
Contact
IPO
Employees
Officers
The intrinsic value of one PGNY stock under the Base Case scenario is 40.42 USD.
Compared to the current market price of 13.9 USD, Progyny Inc is Undervalued by 66%.